Generics batches shipped by sea to the UK are recalled
This article was originally published in Scrip
Karib Kemi Pharm is recalling all unexpired stocks of 111 batches of generic medicines from UK pharmacies and wholesalers as a precaution after the MHRA, the UK drug regulator, found evidence of unsatisfactory conditions during the products' shipment by sea from India.
You may also be interested in...
Local health authorities in Coventry, UK, say it is most unlikely that vaccination with GlaxoSmithKline's Cervarix (human papillomavirus vaccine) was the cause of the death of a 14-year-old schoolgirl on September 28th.
Patents on Janssen-Cilag's (Johnson & Johnson) anti-epileptic Topamax/Epitomax (topiramate) expired in many European countries on September 25th, and generics companies are launching their own versions quickly.
Lilly's Alimta (pemetrexed) has been recommended as a first-line treatment for some patients in England and Wales with non-small cell lung cancer (NSCLC) in binding guidance for the national health service.